retatrutide and ghk cu 60MG Retatrutide + GHK-Cu + Bac
Description
With the effect of lowering ATP, the lowered energy charge in hepatocytes leads to suppression of gluconeogenesis (Owen et al, 2000

The combination addresses both the localized tissue damage (via BPC-157) and systemic inflammation (via TB-500), making it excellent for persistent tendon issues, joint problems, muscle strains, and chronic inflammatory conditions

The maintenance dose can be around 500-1000mg if the initial loading was successful, and can be adjusted based on frequency as well (500mg weekly or 1000mg every 2 weeks)

Nerve growth factor: what can surgeons and oncologists learn from a neurological and psychological biomarker
[DOI] [PubMed] [Google Scholar] Hitomi K., Kitamura M., Sugimura Y

PEPTIDE THERAPY CLINIC EL PASO, TX 20 targeted peptide protocols BPC-157, Sermorelin, CJC-1295/Ipamorelin, GHK-Cu, Tesamorelin, PT-141, Thymosin Alpha-1, and more prescribed and monitored by Celeste Cisneros, FNP-BC
